The biotech giant reported a bigger-than-expected quarterly loss. Finance chief James Mock attributed the loss to a scale down.
It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...
Innovative approaches to streamlining biologics production with integrated continuous technologies. Continuous manufacturing ...
We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to ...
Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...
PETALING JAYA: Sunzen Biotech Bhd is proposing to acquire the remaining 30% of its 70%-owned subsidiary Ecolite Biotech Manufacturing Sdn Bhd, and in the same pattern, the balance 30% of Ecolite ...
With Northway Biotech's expertise in biologics manufacturing, Mallia aims to enter the multi-billion-dollar alopecia market by delivering a safe and effective topical sCD83 treatment designed to ...
Nandita Vijayasimha, Bengaluru Friday, February 14, 2025, 08:00 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results